The Editors of Nature write: Tracking societal impacts encourages academics to pursue them

Quick Read

The group calls for the retraction of six publications by surgeon Paolo Macchiarini regarding the synthetic trachea transplantations that led to the death of at least three patients

Quick Read

Our Peter Young discusses the importance of increasing access and providing context in transparently reporting physician conflicts of interests

Read More

Take-down notices “imminent” as lawsuit is filed alleging widespread copyright infringement

Quick Read

First, Do No Harm

September 21, 2017

Marshaling Clinician Leadership to Counter the Opioid Epidemic | A Special Publication from the National Academy of Medicine

Read More

That’s dangerous. When the results of clinical trials aren’t made public, the consequences can be dangerous — and potentially deadly

Quick Read

If a peer-reviewed paper bears out the news story, “It’s one more step on the path to potential clinical application,” says bioethicist Jeffrey Kahn of Johns Hopkins Berman Institute of Bioethics, who served on a committee convened by the NASEM to address gene editing. The panel’s report earlier this year concluded that a clinical trial involving embryo editing would be ethically allowable under narrow circumstances.

Quick Read

There’s less going on here than meets the eye

Quick Read